Licenses and registrations do not simply transfer
A change of ownership in a pharmacy usually triggers new filings or approvals with the state board, which in New York sits within the State Education Department, and with the DEA for controlled substances. Whether the deal is a purchase of assets or of the owning company affects which registrations must be obtained fresh and which can continue with notice, and the answer differs among agencies. Transferring controlled substance inventory has its own recordkeeping steps. Medicare, Medicaid, and pharmacy benefit manager network enrollments also have to be addressed, and some of those contracts treat a change of ownership as grounds for termination or re-credentialing. Building the closing timeline around these approvals helps avoid a gap during which the store cannot dispense or bill.
Audit exposure and the price
Payers and PBMs audit pharmacies and can seek to recoup payments long after a claim was paid, so a buyer of the owning company may inherit recoupment demands for claims it never submitted. Diligence in pharmacy M&A therefore looks closely at audit history, pending appeals, and billing practices, along with controlled substance dispensing records and any board or DEA inquiries. Prescription files and patient records are valuable assets, and their handling has to follow privacy rules and state pharmacy requirements. Escrows, holdbacks, and indemnities are often sized around these exposures. An asset purchase can limit which liabilities the buyer takes on, though some payer contracts may still carry recoupment rights forward.
What our first review covers
Our first review usually covers the licensing posture of each location, the structure being proposed, and the payer and PBM contracts that make up most of the revenue. For a seller, we look at what a buyer will ask for and what can be cleaned up before a letter of intent is signed. For a buyer, we look at which approvals sit on the critical path and how the purchase agreement should allocate audit and regulatory risk. Restrictive covenants for the selling pharmacist, retention of key staff, and the lease are often negotiated at the same time. Bring recent financials, the current licenses and registrations, the key contracts, and any audit or inspection correspondence.
